FINWIRES · TerminalLIVE
FINWIRES

澳新银行研究称,受石油冲击影响,新西兰消费者信心接近三年来的最低点。

By

-- 澳新银行研究部周五表示,由于迫在眉睫的石油危机引发了人们对整体经济前景和零售商下行风险的担忧,新西兰4月份消费者信心跌至近三年来的最低水平。 澳新银行-罗伊摩根消费者信心指数从3月份的91.3下降11点至4月份的80.3。自中东冲突爆发并推高全球燃油价格以来,该指数在过去两个月已累计下降20点。 通胀预期再次上升约一个百分点至6.6%。认为“现在是购买大型家用物品的好时机”的家庭净比例下降11个百分点至-25,为2024年9月以来的最低水平。 该机构表示,石油危机尚未对家庭收入产生实质性影响,消费者信心下降反映的是生活成本上升,以及零售商对未来业务活动的担忧日益加剧。 然而,由于汽油价格上涨影响了每周预算,消费者信心目前已降至2022年和2023年的水平,显然正在受到打击。 央行补充说,虽然消费者通胀预期并非其关注的重点,因为它们并不直接影响价格制定,但消费者通胀预期(6.6%)与企业工资预期(2.5%)之间的差距正在扩大。

Related Articles

Asia

Telix Says Marketing Authorization Application for Glioma Imaging Candidate Accepted for Review in Europe; Shares Up 3%

Telix Pharmaceuticals (ASX:TLX) said Friday its marketing authorization application filed in Europe for TLX101-Px, its glioma imaging candidate, has been validated and accepted for review, moving into a 210-day active assessment phase.In a statement, the company said it is seeking a broad clinical label, reflective of current clinical practice guidelines, with national marketing authorizations expected to follow shortly after a positive outcome at day 210.The company said it aims to expand patient access to advanced imaging that can distinguish progressive or recurrent glioma from treatment-related changes in both adults and children, with potential for additional future indications.TLX101-Px is also being developed as a patient selection and response assessment tool for Telix's glioblastoma therapy candidate TLX101-Tx, which has been granted orphan drug designation in Europe and the US, per the statement.The phase 3 IPAX-BrIGHT trial of TLX101-Tx in patients with recurrent glioblastoma has started patient dosing internationally and is launching in multiple European countries, the company said.Telix Pharmaceuticals' shares were up 3% in recent Friday trade.

$ASX:TLX
Asia

Zozo's Profit Climbs 6% in Fiscal Year 2025

Zozo's (TYO:3092) profit attributable to owners of the parent rose 5.7% to 47.93 billion yen for the fiscal year 2025 from 45.35 billion yen a year earlier.The shopping mall operator's basic earnings per share increased to 54.11 yen from 50.90 yen a year ago, according to a Tokyo bourse filing on Thursday.Net sales climbed 7.2% to 228.37 billion yen for the full year ended March 31 from 213.13 billion yen in the prior year.The company declared a year-end dividend of 20 yen per share, payable from June 11.For the fiscal year 2026, the company expects attributable profit of 49.7 billion yen, EPS of 56.20 yen, and net sales of 241.9 billion yen.Zozo plans to pay interim and year-end dividends of 20 yen per share each for the year, which is higher than the amount in the year-ago period.

$TYO:3092
Asia

EML Payments Says Regulators Extend Date for Implementation of Required Guarantee Structure

EML Payments (ASX:EML) said the Australian Prudential Regulation Authority (APRA) and Reserve Bank of Australia (RBA) agreed to extend the date for implementation of the required authorized deposit-taking institution guarantee structure, subject to EML Payment Solutions showing "satisfactory progress" towards obtaining the guarantee via periodic reporting, according to a Friday Australian bourse filing.EML Payment Solutions is engaging with several domestic and international financial institutions, as well as legal advisors and trustee service providers, to design the required guarantee structure.The regulators had earlier said that they require the firm to obtain a guarantee from an authorized deposit-taking institution in respect of stored value liabilities for certain EML Payment Solutions programs by Thursday.

$ASX:EML